These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8774641)

  • 1. Growth inhibition of human cervical cancer cells with the recombinant adenovirus p53 in vitro.
    Hamada K; Zhang WW; Alemany R; Wolf J; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Mar; 60(3):373-9. PubMed ID: 8774641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
    Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K; Alemany R; Zhang WW; Hittelman WN; Lotan R; Roth JA; Mitchell MF
    Cancer Res; 1996 Jul; 56(13):3047-54. PubMed ID: 8674061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
    Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
    Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
    Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
    Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
    Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
    Parker LP; Wolf JK; Price JE
    Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus.
    Liu TJ; Zhang WW; Taylor DL; Roth JA; Goepfert H; Clayman GL
    Cancer Res; 1994 Jul; 54(14):3662-7. PubMed ID: 8033080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated p53 growth inhibition of ovarian cancer cells is independent of endogenous p53 status.
    Wolf JK; Mills GB; Bazzet L; Bast RC; Roth JA; Gershenson DM
    Gynecol Oncol; 1999 Nov; 75(2):261-6. PubMed ID: 10525383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nude rat as an orthotopic model for cervical cancer.
    Hamada K; Ueda N; Ito M; Roth JA; Follen M
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S159-65. PubMed ID: 16185752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
    Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
    Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
    Wang Q; Han D; Wang W
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancer.
    Heideman DA; Steenbergen RD; van der Torre J; Scheffner M; Alemany R; Gerritsen WR; Meijer CJ; Snijders PJ; van Beusechem VW
    Mol Ther; 2005 Dec; 12(6):1083-90. PubMed ID: 16085463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.
    Gu W; Putral L; Hengst K; Minto K; Saunders NA; Leggatt G; McMillan NA
    Cancer Gene Ther; 2006 Nov; 13(11):1023-32. PubMed ID: 16810314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effects of Ad5CMV-p53 expression in two human nasopharyngeal carcinoma cell lines.
    Li JH; Li P; Klamut H; Liu FF
    Clin Cancer Res; 1997 Apr; 3(4):507-14. PubMed ID: 9815713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.